Skip to main content
Toggle navigation
Login
Search
Home
Conference Brochure
Tweets by JADPRO Live 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
CE credit available
Pharmacology credit available
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
F
JL1013E
First Prospective Data on Minimal Residual Disease (MRD) Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) Versus Chlorambucil Plus Obinutuzumab (Clb+O) for First-Line Treatment of CLL in Elderly or Unfit Patients: The GLOW Study
Industry Encore Posters
Favorite
JL1014E
First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) + R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL): phase 1/2 data update
Industry Encore Posters
Favorite
